Devonian Health Group Inc. (TSXV:GSD)
Canada
· Delayed Price · Currency is CAD 11.90
0.00 (0.00%)
At close: Apr 23, 2026
Devonian Health Group Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | 2020 - 2016 |
| Revenue | 10.18 | 23.59 | 19.31 | 2.35 | 2.31 | 1.47 | Upgrade
|
| Revenue Growth (YoY) | -66.65% | 22.19% | 723.15% | 1.74% | 56.32% | -31.19% | Upgrade
|
| Cost of Revenue | 5.65 | 15.03 | 11.83 | 1.45 | 1.74 | 1.72 | Upgrade
|
| Gross Profit | 4.53 | 8.56 | 7.48 | 0.89 | 0.56 | -0.24 | Upgrade
|
| Selling, General & Admin | 6.91 | 7.2 | 6.68 | 3.75 | 2.58 | 1.45 | Upgrade
|
| Research & Development | 1.78 | 2.01 | 1.29 | 1.35 | 0.78 | 0.61 | Upgrade
|
| Other Operating Expenses | 0.13 | 0.13 | 0.12 | 0.12 | 0.11 | - | Upgrade
|
| Operating Expenses | 8.82 | 9.33 | 8.09 | 5.22 | 3.47 | 2.07 | Upgrade
|
| Operating Income | -4.28 | -0.77 | -0.61 | -4.32 | -2.91 | -2.31 | Upgrade
|
| Interest Expense | -0.04 | -0.26 | -0.44 | -0.46 | -0.94 | -0.79 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.28 | 0.07 | 0.18 | 0.04 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.36 | -0.29 | Upgrade
|
| EBT Excluding Unusual Items | -4.15 | -0.75 | -0.98 | -4.6 | -3.45 | -3.39 | Upgrade
|
| Impairment of Goodwill | -4.64 | -4.64 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.2 | -0.2 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.05 | Upgrade
|
| Pretax Income | -8.99 | -5.59 | -0.98 | -4.6 | -3.45 | -3.35 | Upgrade
|
| Income Tax Expense | -0.01 | 0.42 | 0.85 | - | - | - | Upgrade
|
| Net Income | -8.98 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 | Upgrade
|
| Net Income to Common | -8.98 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 6.08% | 0.76% | 8.52% | 13.89% | 33.98% | 22.70% | Upgrade
|
| EPS (Basic) | -3.43 | -2.43 | -0.75 | -2.04 | -1.74 | -2.26 | Upgrade
|
| EPS (Diluted) | -3.43 | -2.43 | -0.75 | -2.04 | -1.74 | -2.28 | Upgrade
|
| Free Cash Flow | -9.69 | -1.27 | 5.64 | -4.36 | -2.95 | -1.83 | Upgrade
|
| Free Cash Flow Per Share | -3.70 | -0.51 | 2.30 | -1.93 | -1.49 | -1.24 | Upgrade
|
| Gross Margin | 44.52% | 36.28% | 38.74% | 38.05% | 24.34% | -16.34% | Upgrade
|
| Operating Margin | -42.08% | -3.27% | -3.18% | -184.37% | -126.35% | -156.37% | Upgrade
|
| Profit Margin | -88.16% | -25.49% | -9.46% | -196.11% | -149.59% | -226.92% | Upgrade
|
| Free Cash Flow Margin | -95.20% | -5.36% | 29.20% | -185.74% | -127.77% | -124.31% | Upgrade
|
| EBITDA | -4.08 | -0.47 | -0.22 | -3.92 | -2.07 | -1.3 | Upgrade
|
| EBITDA Margin | -40.11% | -1.99% | -1.14% | -167.35% | -89.81% | -87.87% | Upgrade
|
| D&A For EBITDA | 0.2 | 0.3 | 0.39 | 0.4 | 0.84 | 1.01 | Upgrade
|
| EBIT | -4.28 | -0.77 | -0.61 | -4.32 | -2.91 | -2.31 | Upgrade
|
| EBIT Margin | -42.08% | -3.27% | -3.18% | -184.37% | -126.35% | -156.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.